KRBP Market Cap History



Below is a table of the KRBP market cap history going back to 10/16/2020:

Date KRBP Market Cap
10/16/202083.22M
11/27/202059.47M
3/31/202169.00M
5/14/202142.57M
8/13/202147.70M
3/11/202211.80M
4/8/202213.09M
5/13/20225.23M
8/12/20227.76M
11/14/20225.07M
4/14/20234.57M
4/25/20233.87M
5/12/20233.76M
8/11/20232.62M

Also see: KRBP Shares Outstanding History
and KRBP YTD Return
KRBP Historical Market Cap:
-70.66% CAGR
KRBP Historical Market Cap: +-70.66% CAGR

Mouse over chart for data details
10/16/2020 ...8/11/2023
Kiromic BioPharma is an artificial intelligence driven, end-to-end Chimeric Antigen Receptor T cell and gene therapy company. Co.'s Procel, Isocel, and Deltacel platforms consist of allogeneic cell therapy product candidates that are in the preclinical development stage. Co.'s Procel product candidate consists of engineered GDTs that target PD-L1. Co.'s Isocel product candidate consists of engineered Gamma Delta T cells that target Mesothelin Isoform 2 positive tumors. Co.'s Deltacel product candidate consists of non-engineered GDTs that have been expanded and activated ex- vivo through a process, and are used to treat solid tumors regardless of the specific tumor antigen expression. We show 14 historical shares outstanding datapoints in our KRBP shares outstanding history coverage, used to compute KRBP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KRBP market cap history over the course of time is important for investors interested in comparing KRBP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KRBP versus a peer is one thing; comparing KRBP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KRBP can fluctuate over the course of history. With this page we aim to empower investors researching KRBP by allowing them to research the KRBP market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree KRBP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Kiromic BioPharma (KRBP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

KRMD Market Cap History
KRON Market Cap History
KROS Market Cap History
KRRO Market Cap History
KRTX Market Cap History
KRYS Market Cap History
KTRA Market Cap History
KTTA Market Cap History
KTWO Market Cap History
KURA Market Cap History
More Healthcare companies »

 

KRBP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.